
ThirdAge
<img alt="" height="1" width="1" />
Novartis says Afinitor shrinks some brain tumors
BusinessWeek
Swiss drug maker Novartis reported Friday that its drug Afinitor successfully shrunk non-cancerous brain tumors in one third of patients with a rare disease. The company reported results from a study of patients with tuberous sclerosis, a rare genetic ...
Novartis' Afinitor reduces SEGA tumour sizeReuters
SEGA Tumors Respond to mTOR InhibitorMedPage Today
Another study-data boost for Novartis' AfinitorFiercePharma
RTT News -Proactive Investors USA & Canada -ThirdAge
all 35 news articles »
More...